Search Results

There are 1535 results for: content related to: Nitazoxanide plus pegylated interferon and ribavirin in the treatment of genotype 4 chronic hepatitis C, a randomized controlled trial

  1. You have free access to this content
    Nitazoxanide for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Kristiana Nikolova, Christian Gluud, Berit Grevstad and Janus C Jakobsen

    Published Online : 6 APR 2014, DOI: 10.1002/14651858.CD009182.pub2

  2. You have free access to this content
    The future for the treatment of genotype 4 chronic hepatitis C

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 146–150, G. Esmat, M. El Raziky, M. El Kassas, M. Hassany and M.E. Gamil

    Article first published online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02704.x

  3. You have free access to this content
    Alternative interferons and immunomodulators in the treatment of hepatitis C

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 133–138, Hawwa Alao and T. Jake Liang

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12402

  4. In Vitro Effect of Nitazoxanide Against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis Trophozoites

    Journal of Eukaryotic Microbiology

    Volume 49, Issue 3, May 2002, Pages: 201–208, ROBERTO CEDILLO-RIVERA, BIBIANA CHÁVEZ, ARTURO GONZÁLEZ-ROBLES, AMPARO TAPIA and LILIÁN YÉPEZ-MULIA

    Article first published online : 11 JUL 2005, DOI: 10.1111/j.1550-7408.2002.tb00523.x

  5. Effects of triple-drug therapy with nitazoxanide, high-dose ribavirin and peginterferon-α-2a in patients with chronic hepatitis C

    Hepatology Research

    Volume 43, Issue 6, June 2013, Pages: 589–595, P. Patrick Basu, Krishna Rayapudi, Niraj James Shah, Nithya Krishnaswamy and Robert S. Brown

    Article first published online : 11 DEC 2012, DOI: 10.1111/hepr.12013

  6. Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review

    Liver International

    Volume 33, Issue 6, July 2013, Pages: 894–903, Victoria A. Sublette, Mark W. Douglas, Kirsten McCaffery, Jacob George and Kathryn Nicholson Perry

    Article first published online : 14 APR 2013, DOI: 10.1111/liv.12138

  7. You have free access to this content
    Antioxidants as therapeutic agents for liver disease

    Liver International

    Volume 31, Issue 10, November 2011, Pages: 1432–1448, Ashwani K. Singal, Sarat C. Jampana and Steven A. Weinman

    Article first published online : 29 JUL 2011, DOI: 10.1111/j.1478-3231.2011.02604.x

  8. You have free access to this content
    Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

    Liver International

    Volume 33, Issue s1, February 2013, Pages: 137–150, Geoffrey Dusheiko

    Article first published online : 3 JAN 2013, DOI: 10.1111/liv.12078

  9. Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

    Liver International

    Volume 34, Issue 6, July 2014, Pages: 869–889, Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal and Stanislas Pol

    Article first published online : 25 NOV 2013, DOI: 10.1111/liv.12363

  10. Analyzing the relationship of QT interval and exposure to Nitazoxanide, a prospective candidate for influenza antiviral therapy—A formal TQT study

    The Journal of Clinical Pharmacology

    Volume 54, Issue 9, September 2014, Pages: 987–994, Jörg Täubel, Ulrike Lorch, Jean-François Rossignol, Georg Ferber and A. John Camm

    Article first published online : 15 APR 2014, DOI: 10.1002/jcph.300

  11. You have full text access to this OnlineOpen article
    Clinical utility of viscoelastic tests of coagulation in patients with liver disease

    Liver International

    Volume 33, Issue 7, August 2013, Pages: 961–974, Susan V. Mallett, Pratima Chowdary and Andrew K. Burroughs

    Article first published online : 3 MAY 2013, DOI: 10.1111/liv.12158

  12. You have free access to this content
    Appraising cardiac dysfunction in liver transplantation: an ongoing challenge

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 12–29, Ahmed Zaky and Karim Bendjelid

    Article first published online : 5 JUN 2014, DOI: 10.1111/liv.12582

  13. You have free access to this content
    Effect of Nitazoxanide on Erythrocytes

    Basic & Clinical Pharmacology & Toxicology

    Volume 114, Issue 5, May 2014, Pages: 421–426, Markus Arnold, Elisabeth Lang, Paola Modicano, Rosi Bissinger, Caterina Faggio, Majed Abed and Florian Lang

    Article first published online : 11 DEC 2013, DOI: 10.1111/bcpt.12171

  14. You have free access to this content
    Toll-like receptors and liver disease

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 184–196, Vivek Kesar and Joseph A. Odin

    Article first published online : 2 OCT 2013, DOI: 10.1111/liv.12315

  15. You have free access to this content
    Cryptosporidium infection after renal transplantation in an endemic area

    Transplant Infectious Disease

    Volume 17, Issue 1, February 2015, Pages: 48–55, D. Bhadauria, A. Goel, A. Kaul, R.K. Sharma, A. Gupta, V. Ruhela, A. Gupta, H. Vardhan and N. Prasad

    Article first published online : 12 JAN 2015, DOI: 10.1111/tid.12336

  16. You have free access to this content
    Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

    Liver International

    Volume 32, Issue 5, May 2012, Pages: 712–731, Marina Berenguer, Ramón Charco, Juan Manuel Pascasio and Jose Ignacio Herrero, on behalf of the Sociedad Española de Trasplante Hepático

    Article first published online : 4 JAN 2012, DOI: 10.1111/j.1478-3231.2011.02731.x

  17. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease

    Liver International

    Volume 34, Issue 6, July 2014, Pages: e128–e135, Shira Zelber-Sagi, Federico Salomone, Hanny Yeshua, Roni Lotan, Muriel Webb, Zamir Halpern, Erwin Santo, Ran Oren and Oren Shibolet

    Article first published online : 14 OCT 2013, DOI: 10.1111/liv.12318

  18. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes

    Liver International

    Volume 34, Issue 1, January 2014, Pages: 58–68, Zhao H. Hou, Qiu J. Han, Cai Zhang, Zhi G. Tian and Jian Zhang

    Article first published online : 24 JUL 2013, DOI: 10.1111/liv.12244

  19. Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo

    Liver International

    Volume 34, Issue 3, March 2014, Pages: 447–461, Annabelle Vogt, Elisabeth Sievers, Veronika Lukacs-Kornek, Georges Decker, Esther Raskopf, Nadja Meumann, Hildegard Büning, Tilman Sauerbruch, Christian P. Strassburg, Ingo G. H. Schmidt-Wolf and Maria A. Gonzalez-Carmona

    Article first published online : 2 SEP 2013, DOI: 10.1111/liv.12284

  20. You have free access to this content
    New therapeutic perspectives in HBV: when to stop NAs

    Liver International

    Volume 34, Issue s1, February 2014, Pages: 146–153, Cristina Pérez-Cameo, Mònica Pons and Rafael Esteban

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12398